Coverage
-
November 08, 2016
The South Carolina federal judge overseeing multidistrict litigation over claims that Pfizer's Lipitor causes Type 2 diabetes on Monday said that roughly 70 suits should be sent back to California, finding that the pharmaceutical giant can't show that claims against a distributor have no hope of survival.
8 other articles on this case.
View all »